Murex Diagnostics/Organon Teknika
This article was originally published in The Gray Sheet
Executive Summary
Permanently enjoined from manufacturing and selling hepatitis C virus immunoassays that infringe patents held by Chiron, according to a Nov. 29 ruling by the High Court of Justice for England and Wales on a suit brought by Chiron and its marketing partner, Johnson & Johnson's Ortho Diagnostic Systems. Murex said it will appeal the judge's decision to stay the injunction and "will sustain an annual negative revenue impact of $3 mil. on sales of hepatitis C products in the U.K. pending the outcome of the appeal." Damages will be determined at a future hearing